Tacrolimus and Xopenex hfa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tacrolimus (tacrolimus) and Xopenex hfa (levalbuterol tartrate). Common drug interactions include blood pressure increased among females.

The phase IV clinical study analyzes what interactions people have when they take Tacrolimus and Xopenex hfa. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Tacrolimus?

Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 116,160 Tacrolimus users. Check the latest studies of Tacrolimus.

What is Xopenex hfa?

Xopenex hfa has active ingredients of levalbuterol tartrate. It is often used in asthma. eHealthMe is studying from 2,529 Xopenex hfa users. Check the latest studies of Xopenex hfa.

On Nov, 16, 2025

19 people who take Tacrolimus and Xopenex hfa together, and have interactions are studied.

Tacrolimus and Xopenex hfa drug interactions.

What are the common drug interactions of Tacrolimus and Xopenex Hfa, by gender? *:

female:

Blood pressure increased
Diarrhoea
Serum ferritin decreased
Stridor
Tendonitis (a condition that causes pain and swelling of tendons)
Urinary incontinence (inability to control the flow of urine and involuntary urination)
Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Malaise (a feeling of general discomfort or uneasiness)
Anaemia (lack of blood)
Aphagia (inability or refusal to swallow)

male:

n/a

What are the common drug interactions of Tacrolimus and Xopenex Hfa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Malaise (a feeling of general discomfort or uneasiness)

20-29:

Cystic fibrosis (disease of the secretary glands)
Disease complication
Local swelling (swelling at the site of some application of substance or injury)
Swelling face

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Cardiac failure congestive
Chest pain
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Ear pain
Erythema (redness of the skin)
Fluid intake reduced
Middle ear effusion (fluid in middle ear)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Pneumonia
Renal mass (mass in kidney)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 36.84%
Pain: 2 people, 10.53%
Osteoporosis (bones weak and more likely to break): 2 people, 10.53%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 2 people, 10.53%
Cystic Fibrosis (disease of the secretary glands): 2 people, 10.53%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 5.26%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 5.26%
Osteoporotic Fracture (fracture due to weak bone): 1 person, 5.26%
Neoplasm Malignant (cancer tumour): 1 person, 5.26%
Nausea And Vomiting: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Tacrolimus and Xopenex hfa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously